130 related articles for article (PubMed ID: 33625351)
21. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
[TBL] [Abstract][Full Text] [Related]
22. A field evaluation of the Hardy TB MODS Kit™ for the rapid phenotypic diagnosis of tuberculosis and multi-drug resistant tuberculosis.
Martin L; Coronel J; Faulx D; Valdez M; Metzler M; Crudder C; Castillo E; Caviedes L; Grandjean L; Rodriguez M; Friedland JS; Gilman RH; Moore DA
PLoS One; 2014; 9(9):e107258. PubMed ID: 25225802
[TBL] [Abstract][Full Text] [Related]
23. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
[TBL] [Abstract][Full Text] [Related]
24. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
[TBL] [Abstract][Full Text] [Related]
26. Performance of Xpert MTB/RIF for detection of Mycobacterium tuberculosis and rifampicin resistance in pus aspirates.
Set R; Bankar S; Sharma D; Shah D; Shastri J
Indian J Tuberc; 2019 Oct; 66(4):433-436. PubMed ID: 31813428
[TBL] [Abstract][Full Text] [Related]
27. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
29. Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis.
Kurbatova EV; Kaminski DA; Erokhin VV; Volchenkov GV; Andreevskaya SN; Chernousova LN; Demikhova OV; Ershova JV; Kaunetis NV; Kuznetsova TA; Larionova EE; Smirnova TG; Somova TR; Vasilieva IA; Vorobieva AV; Zolkina SS; Cegielski JP
Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):735-43. PubMed ID: 23263819
[TBL] [Abstract][Full Text] [Related]
30. Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic Tests.
Ardizzoni E; Ariza E; Mulengwa D; Mpala Q; de La Tour R; Maphalala G; Varaine F; Kerschberger B; Graulus P; Page AL; Niemann S; Dreyer V; Van Deun A; Decroo T; Rigouts L; de Jong BC
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722892
[TBL] [Abstract][Full Text] [Related]
31. Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia.
Bates M; Ahmed Y; Chilukutu L; Tembo J; Cheelo B; Sinyangwe S; Kapata N; Maeurer M; O'Grady J; Mwaba P; Zumla A
Trop Med Int Health; 2013 Sep; 18(9):1134-1140. PubMed ID: 23834035
[TBL] [Abstract][Full Text] [Related]
32. Xpert MTB/RIF®, a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis.
Bowles EC; Freyée B; van Ingen J; Mulder B; Boeree MJ; van Soolingen D
Int J Tuberc Lung Dis; 2011 Jul; 15(7):988-9. PubMed ID: 21682978
[TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
[TBL] [Abstract][Full Text] [Related]
34. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF.
Ullah I; Javaid A; Masud H; Ali M; Basit A; Ahmad W; Younis F; Yasmin R; Khan A; Jabbar A; Husain M; Butt ZA
J Med Microbiol; 2017 Apr; 66(4):412-418. PubMed ID: 28425873
[TBL] [Abstract][Full Text] [Related]
35. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
[TBL] [Abstract][Full Text] [Related]
36. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration.
Tadesse M; Aragaw D; Rigouts L; Abebe G
Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
38. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh.
Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M
Indian J Med Microbiol; 2017; 35(4):568-574. PubMed ID: 29405151
[TBL] [Abstract][Full Text] [Related]
40. Isoniazid and rifampin drug susceptibility testing: application of 2,3,5-triphenyl tetrazolium chloride assay and microscopic-observation drug-susceptibility assay directly on Ziehl-Neelsen smear positive sputum specimens.
Shinu P; Singh V; Nair A
Braz J Infect Dis; 2016; 20(1):33-40. PubMed ID: 26638012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
